Navigating biosimilar transitions in IV rituximab therapy: Efficacy and safety insights from a real-world switching study
Journal of Oncology Pharmacy Practice
Published online on January 06, 2026
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
AimThis study evaluates the efficacy and safety of rituximab biosimilars (BRs) compared to the original rituximab (MAB) administered intravenously, particularly from the aspect of switching and switch directions.Materials and MethodsThis retrospective ...
AimThis study evaluates the efficacy and safety of rituximab biosimilars (BRs) compared to the original rituximab (MAB) administered intravenously, particularly from the aspect of switching and switch directions.Materials and MethodsThis retrospective ...